WhatsApp Skip to main content

Dr. Harsh J Shah

Large GIST? Why Tablets May Come Before Surgery

Last updated: 17-Nov-2026

Tapping Book on WhatsApp will likely open the WhatsApp app on your phone.

Dr Harsh Shah, stomach cancer surgeon, Ahmedabad

Dr Harsh Shah
MS, MCh (Surgical Gastroenterology), DrNB (Surgical Gastroenterology)
Registered with Gujarat Medical Council, Reg. No. G-38738
Stomach Cancer Surgeon
Dr. Jivraj Mehta Hospital, Vasna, Ahmedabad · 18 years of experience

In short

A GIST is called borderline resectable when it can be removed only by a large operation, such as a total gastrectomy, and locally advanced when it presses on or grows into nearby organs.

For these tumours, imatinib tablets are often given first, usually for six to twelve months, to shrink the tumour before the operation. The gene result must be known before the first tablet.

The aim is a smaller operation that keeps the organ and removes the tumour whole, not a delay for its own sake.

For the whole story of GIST, from the first test to imatinib and surgery, read our GIST treatment in Ahmedabad page. This post explains the case where tablets come before the operation.

What counts as locally advanced or borderline resectable?

Both words describe a tumour that is hard to remove safely in one step. Borderline is the surgeon’s word. Locally advanced is the staging word.

Which kind of GIST, and what is usually done first
SituationExampleUsual first step
Can be removed whole with a small operationA moderate stomach tumour on the wallOperation first
Borderline: removal possible only with a large operationA tumour at the junction of food pipe and stomach that would need the whole stomach removedImatinib first, then re-assess
Locally advanced: touches nearby organs, no spread far awayA very large stomach tumour against the pancreas, spleen and colonImatinib first, then operate if it shrinks enough
Cannot be removed even after tabletsTumour wrapped around the main blood vessels, or seeding through the bellyTreated like spread disease
Came back in the same placeA return in the pelvis after an earlier operationImatinib, then operation

Where a tumour sits in this table is decided by the surgeon from the scans, together with the oncologist, the pathologist and the radiologist. It is never decided by a scan report alone.

Why not operate straight away?

Because the first operation is the strongest chance to remove a GIST cleanly. If it would be a morbid operation, shrinking the tumour first can make it safer.

  • A smaller tumour can often be taken out with a wedge or a short segment, keeping the stomach, rectum or sphincter.
  • A shrunk and firmer tumour is less likely to tear during the operation, and a tear is the thing we most want to avoid.
  • The edge of the removed specimen is more likely to be clear of tumour cells.
  • An operation that would otherwise take the whole stomach, the pancreas head or the lower rectum may no longer be needed.

This only helps when the tumour answers to imatinib. That is why the next step is a gene test, not a prescription.

What must be done before the first tablet?

A tissue diagnosis and a gene result. Starting tablets on a scan alone is not accepted practice.

  • Biopsy. For a stomach, food pipe, duodenum or rectum tumour, a fine needle sample taken through the scope is preferred. It is small and passes through the gut wall, not through the belly.
  • Gene test. KIT and PDGFRA changes are looked for. It tells us whether imatinib will work and at what dose.
  • Scans. A contrast CT of the chest, belly and pelvis for a baseline and to look for spread. A PET scan where available gives a second baseline.
  • Blood tests, heart tracing and a team review. The decision to give tablets first should never be one doctor’s call.

A small stomach lump where the operation is simple does not need a biopsy at all, because the operation itself answers the question. The scope and scan tests are explained in how a GIST is confirmed with CT, scope and biopsy, and the gene result in what your GIST gene report means.

Which tablet, which dose, for how long?

Imatinib once a day, with food. The dose follows the gene result, and the usual course before surgery is six to twelve months.

  • A KIT exon 11 change, or a result not yet known: 400 mg a day. This group responds most reliably.
  • A KIT exon 9 change: a higher dose, 800 mg a day in two parts, because the lower dose works less well.
  • PDGFRA D842V: imatinib does not work. Another tablet exists for this change but may be hard to get, so surgery or a trial is often discussed instead.
  • SDH-deficient or no KIT or PDGFRA change: imatinib usually does little, so the plan is reconsidered before starting.

The tablets are not stopped the moment the tumour looks smaller. They continue until two scans, eight to twelve weeks apart, show no further shrinkage. That plateau usually comes by six to nine months, and it does not mean the tablet has failed. It means the most has been gained.

How do we know the tablets are working?

By scans at eight to twelve weeks, read with methods made for GIST. A responding tumour may soften and look darker on CT without shrinking much.

  • Ordinary size-only criteria under-call the response. A tumour can change inside long before it gets smaller.
  • The GIST-specific method counts either a fall in size or a fall in density on the contrast scan as a response.
  • A PET scan, where available, can show response within days or weeks, because the tumour stops taking up sugar.
  • Tablets also bring side effects to watch: swelling around the eyes, tiredness, loose stools and low blood counts. Blood tests are done through the course.

If the scans show growth instead, the gene result is looked at again, and the options are an earlier operation or a different tablet.

When is the operation done, and what changes?

At the plateau, when the tumour is as small as it will get and a clean, organ-saving removal is possible.

  • Imatinib is usually stopped one to three days before the operation and restarted about five to seven days after, once the patient is eating and healing.
  • The operation removes the tumour whole, in a bag if it is laparoscopic, with no squeezing of the tumour.
  • Where the tumour has shrunk away from nearby organs, a wedge or segment can replace a large resection.
  • The specimen is studied in full, and the final risk group is set after surgery.

The operation itself, and the options by site, are in our post on GIST surgery for a tumour that has not spread.

What if the tumour does not shrink?

Then the team does not wait. The reason is looked for, and a decision is made on the next scan.

  • If the tumour is still shrinking, tablets continue for a few more months and a repeat scan follows.
  • If it has plateaued but a clean removal is still not possible, surgery with the clearest margin achievable is weighed against continuing tablets alone.
  • If it has grown, a second tablet may be started and the plan reviewed with the team. Second-line choices are in what happens when imatinib stops working.
  • If the cause is a tumour that never responds, such as the D842V change, surgery is not delayed for months of tablets.

Do tablets continue after the operation?

Usually yes, if the final report puts the tumour in a high-risk group. The months taken before surgery do not count toward that course.

  • Imatinib for about three years after surgery is the usual advice for a high-risk GIST.
  • The clock is usually restarted at the operation, though the team sets the course from your final report and your gene result.
  • Scans follow on a schedule set by the risk group.

How the risk group is worked out is explained in your GIST risk group and stage, and the order of tablets and surgery in surgery or imatinib first: how the order is set.

What should you ask your team?

Five questions cover it. Ask them with your scans and gene report in hand.

  1. Is my tumour borderline or locally advanced, and which operation would it need today?
  2. What is my gene result, and does it support imatinib?
  3. Which dose, and when is my first scan to check the response?
  4. What size or change would tell you it is time to operate?
  5. What happens if it does not shrink?

If an answer is missing, bring your reports to Dr Shah. He will review them and tell you what is still needed before a decision.

Frequently asked questions

What does borderline resectable GIST mean?

It means the tumour can be removed only by a large operation, such as taking the whole stomach or the lower rectum. Shrinking it first with imatinib may allow a smaller operation that keeps the organ.

Is it dangerous to wait for tablets to work?

Not when the plan is made by the team and scans are repeated every eight to twelve weeks. If the tumour grows, the plan changes early. The wait is chosen only when the gene result predicts a response.

Do I need a gene test before imatinib?

Yes. It shows whether imatinib will work and at what dose. A tumour with the PDGFRA D842V change does not respond, so tablets first would only delay the operation.

How long are tablets taken before surgery?

Usually six to twelve months, until two scans show no further shrinkage. The plateau comes by about six to nine months in many people.

Will the operation still be needed after the tumour shrinks?

Yes, in most people. Tablets shrink a GIST but rarely remove every cell, so the operation is still the step that removes it for good.

When are tablets stopped around the operation?

Usually one to three days before, and restarted about five to seven days after, once you are eating and healing well. Your surgeon will give the exact days.

Will I need tablets after surgery too?

If the final report puts the tumour in a high-risk group, about three years of imatinib is usual. The months before surgery are not counted toward that course.

Related pages

For the full picture of GIST and its treatment, start at the GIST treatment in Ahmedabad page. For questions before you travel, call +91-63555-64601.

Where Dr Harsh Shah sees patients and operates

Dr Harsh Shah — Dr. Jivraj Mehta Hospital, Vasna, Ahmedabad
Dr. Jivraj Mehta Hospital, Dr Jivraj Mehta Marg, Vasna, Ahmedabad 380007.
Consultations, review of reports and scans, operations and follow-up. OPD Monday to Saturday, 9 am to 5 pm.
Appointments: +91-63555-64601 · +91-63590-11009 · Hospital 079-2663 6363
Directions to the hospital · WhatsApp +91-63555-64601

Told your GIST is too big or too awkward to operate on straight away? That does not mean it cannot be treated. For some tumours the safest plan is tablets first and the operation later, so that a smaller, simpler operation becomes possible. Dr Harsh Shah, a stomach cancer surgeon in Ahmedabad, reviews your scans and gene report and explains in plain words which order suits you. Bring your reports. You can call us or book by message. Call For Appointment Book on WhatsApp Tapping Book on WhatsApp will likely open the WhatsApp app on your phone.

Tapping Book on WhatsApp will likely open the WhatsApp app on your phone.

Get health updates from Dr Harsh Shah on WhatsApp

Swasth Parivar: every week, practical advice on recovery, diet and warning signs. No advertising. Stop any time.

Your number is used for these updates and for the clinic to reach you. It is never sold or passed on. To stop, reply STOP on WhatsApp.

Dr. Harsh J Shah
Dr Harsh Shah, Gastro, Cancer & Laparoscopic Surgeon, Ahmedabad
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.